Skip to main content

Hospital 30-Day, All-Cause, Risk-Standardized Mortality Rate (RSMR) Following Heart Failure (HF) Hospitalization

CBE ID
0229
1.4 Project
Cardiovascular
Endorsed
Endorsement Status
Endorsed
1.1 New or Maintenance
Maintenance
E&M Cycle
Fall 2020
Is Under Review
No
Next Planned Maintenance Review
Cardiovascular Fall 2024
1.3 Measure Description

The measure estimates a hospital-level 30-day, all-cause, risk-standardized mortality rate for patients discharged from the hospital with a principal diagnosis of HF. Mortality is defined as death for any cause within 30 days after the date of admission for the index admission. CMS annually reports the measure for patients who are 65 years or older and enrolled in fee-for-service (FFS) Medicare and hospitalized in non-federal hospitals or are patients hospitalized in Veterans Health Administration (VA) facilities.

    • 1.14 Numerator

      The outcome for this measure is 30-day all-cause mortality. We define mortality as death from any cause within 30 days from the date of admission for patients 65 and older hospitalized with a principal diagnosis of HF.

    • 1.15 Denominator

      This claims-based measure is used for a cohort of patients aged 65 years or older.

      The cohort includes admissions for patients aged 65 years and older discharged from the hospital with a principal discharge diagnosis of HF and with a complete claims history for the 12 months prior to admission. The measure is publicly reported by CMS for those patients 65 years and older who are Medicare FFS or VA beneficiaries admitted to non-federal or VA hospitals, respectively.

      Additional details are provided in S.7 Denominator Details.

    • Exclusions

      The mortality measures exclude index admissions for patients:

      1. Discharged alive on the day of admission or the following day who were not transferred to another acute care facility;
      2. With inconsistent or unknown vital status or other unreliable demographic (age and gender) data;
      3. Enrolled in the Medicare hospice program or used VA hospice services any time in the 12 months prior to the index admission, including the first day of the index admission;
      4. Discharged against medical advice (AMA); or
      5. Patients undergoing left ventricular assist device (LVAD) implantation or heart transplantation during an index admission or who have a history of LVAD or heart transplant in the preceding year.

      For patients with more than one admission for a given condition in a given year, only one index admission for that condition is randomly selected for inclusion in the cohort for each year.

    • Most Recent Endorsement Activity
      Endorsed Cardiovascular Fall Cycle 2020
      Initial Endorsement
      Last Updated